HC Wainwright Reiterates Buy Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 464.97% from the stock’s current price. ZNTL has been […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 464.97% from the stock’s current price. ZNTL has been […]
